Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Geyer

Showing results (71-80 of 617) with videos related to

Pageof 62
Sort By:
Expert Opinion on Therapeutic Targets|January 31, 2003
Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug developmentNorman C Waters, Jeanne A Geyer
Psychopharmacology|January 1, 1995
8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of actionT A Sipes, M A Geyer
Psychopharmacology|January 1, 1993
Quantitative assessment of the microstructure of rat behavior: I, f(d), the extension of the scaling hypothesisM P Paulus, M A Geyer
Psychopharmacology|January 1, 1993
Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in ratsK M Krebs, M A Geyer
Psychopharmacology|January 1, 1991
Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamineR S Mansbach, M A Geyer
European Journal of Pharmacology|November 8, 1988
Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligandsR S Mansbach, M A Geyer
Pharmacology, Biochemistry, and Behavior|March 1, 1993
Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophreniaN R Swerdlow, M A Geyer
Biological Psychiatry|February 6, 2010
Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors?Jared W Young, Mark A Geyer
Brain Research Bulletin|December 26, 2001
A systems model of altered consciousness: integrating natural and drug-induced psychosesF X Vollenweider, M A Geyer
Physiology & Behavior|September 25, 1999
Ontogeny of isolation rearing-induced deficits in sensorimotor gating in ratsV P Bakshi, M A Geyer
Pageof 62

Showing results (71-80 of 617) with videos related to

Sort By:
Pageof 62
Expert Opinion on Therapeutic Targets|January 31, 2003
Cyclin-dependent protein kinases as therapeutic drug targets for antimalarial drug developmentNorman C Waters, Jeanne A Geyer
Psychopharmacology|January 1, 1995
8-OH-DPAT disruption of prepulse inhibition in rats: reversal with (+)WAY 100,135 and localization of site of actionT A Sipes, M A Geyer
Psychopharmacology|January 1, 1993
Quantitative assessment of the microstructure of rat behavior: I, f(d), the extension of the scaling hypothesisM P Paulus, M A Geyer
Psychopharmacology|January 1, 1993
Behavioral characterization of alpha-ethyltryptamine, a tryptamine derivative with MDMA-like properties in ratsK M Krebs, M A Geyer
Psychopharmacology|January 1, 1991
Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamineR S Mansbach, M A Geyer
European Journal of Pharmacology|November 8, 1988
Blockade of potentiated startle responding in rats by 5-hydroxytryptamine1A receptor ligandsR S Mansbach, M A Geyer
Pharmacology, Biochemistry, and Behavior|March 1, 1993
Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophreniaN R Swerdlow, M A Geyer
Biological Psychiatry|February 6, 2010
Action of modafinil--increased motivation via the dopamine transporter inhibition and D1 receptors?Jared W Young, Mark A Geyer
Brain Research Bulletin|December 26, 2001
A systems model of altered consciousness: integrating natural and drug-induced psychosesF X Vollenweider, M A Geyer
Physiology & Behavior|September 25, 1999
Ontogeny of isolation rearing-induced deficits in sensorimotor gating in ratsV P Bakshi, M A Geyer
Pageof 62